Table 2 Approval status of selected drugs for specific treatment of osteoporosis

Alendronate 70 mg/week

X

–

Alendronate 10 mg/day

X

X

Risedronate 35 mg/week

X

X

Ibandronate oral (150 mg/month) and iv (3 mg/3 months

X

–

Zoledronate iv 5 mg/year

X

X

Denosumab 60 mg sc/6 months

X

X^a

Teriparatide 20 ug sc/day for max 24 months

X

X